Articles with the topic: featured

ASO gene silencing reaches further, lasts longer

Silencing the Huntingtin gene using ASO drugs reaches further, lasts longer and is safe. Human trial soon?

Dr Nayana Lahiri | June 21, 2012

Phosphodiesterase inhibitors: new HD drugs entering trials soon

CHDI and Pfizer announce exciting animal work and plans for a human trial with a drug targeting 'phosphodiesterases'.

Carly Desmond | June 07, 2012

What's the connection between Huntington's Disease and cancer?

HD patients are less likely to get cancer, according to a study from Sweden - what does this mean?

Dr Jeff Carroll | April 25, 2012

2012 Therapeutics Conference: a retrospective

HDBuzz looks back at the 2012 Huntington's Disease Therapeutics Conference

Professor Ed Wild | April 03, 2012

HDYO! Huntington's Disease Youth Organization goes live

The Huntington's Disease Youth Organization website has just launched and its website is now active at www.hdyo.org

Professor Ed Wild | February 10, 2012

2011 - a year in Huntington's disease research

Looking back at a year in Huntington's disease research - and the first year of HDBuzz

Professor Ed Wild | December 31, 2011

TRACK-HD reveals changes in HD mutation carriers, empowering future trials

Follow-up data from TRACK-HD study proves that we have the tests we need to successfully run drug trials for HD

Prof Anne Rosser | December 05, 2011

HDAC inhibitors and a possible 'blood biomarker'

HDAC inhibitors explained, plus how new HDAC-related Huntington's disease research might help us find biomarkers

Professor Ed Wild | October 14, 2011

Oz Buzz Video: Day 2

The final day of Oz Buzz: the nightly news, interviews and features presentation from the HD World Congress 2011

Dr Jeff Carroll | September 16, 2011

Start here

New to HD research? Click here to get an overview